Drug Repurposing Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Financial Impact Analysis)
ID : MRU_
4948 | Date :
Jan, 2023 | Pages :
186 | Region : Global |
Publisher : 99 Strategy
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.
The Global Drug Repurposing Market had reached xxx million USD with a CAGR xx from 2018-2022. Later on, it will go to xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Drug Repurposing Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
In Market segmentation by applications :
Hospitals
Ambulatory Surgical Centers
Others
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Drug Repurposing Market for the forecast period 2023-2030?
• What are the driving forces in the Drug Repurposing Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Drug Repurposing industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Drug Repurposing Market Size Growth Rate by Type (2020-2030)
1.3.2 Oncology
1.3.3 CNS Diseases
1.3.4 Neurodegenerative Diseases
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Drug Repurposing Market Share by Application (2020-2030)
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repurposing Market Size
2.1.1 Global Drug Repurposing Revenue 2015-2030
2.1.2 Global Drug Repurposing Sales 2015-2030
2.2 Drug Repurposing Growth Rate by Regions
2.2.1 Global Drug Repurposing Sales by Regions 2018 - 2022
2.2.2 Global Drug Repurposing Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Drug Repurposing Sales by Manufacturers
3.1.1 Drug Repurposing Sales by Manufacturers 2018 - 2022
3.1.2 Drug Repurposing Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 Drug Repurposing Revenue by Manufacturers (2018 - 2022)
3.2.2 Drug Repurposing Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.3 Drug Repurposing Price by Manufacturers
3.4 Key Manufacturers Drug Repurposing Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Drug Repurposing Market
3.6 Key Manufacturers Drug Repurposing Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oncology Sales and Revenue (2018 - 2022)
4.1.2 CNS Diseases Sales and Revenue (2018 - 2022)
4.1.3 Neurodegenerative Diseases Sales and Revenue (2018 - 2022)
4.1.4 Others Sales and Revenue (2018 - 2022)
4.2 Global Drug Repurposing Sales Market Share by Type
4.3 Global Drug Repurposing Revenue Market Share by Type
4.4 Drug Repurposing Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Drug Repurposing Sales by Application
6 United States
6.1 United States Drug Repurposing Breakdown Data by Company
6.2 United States Drug Repurposing Breakdown Data by Type
6.3 United States Drug Repurposing Breakdown Data by Application
7 European Union
7.1 European Union Drug Repurposing Breakdown Data by Company
7.2 European Union Drug Repurposing Breakdown Data by Type
7.3 European Union Drug Repurposing Breakdown Data by Application
8 China
8.1 China Drug Repurposing Breakdown Data by Company
8.2 China Drug Repurposing Breakdown Data by Type
8.3 China Drug Repurposing Breakdown Data by Application
9 Rest of World
9.1 Rest of World Drug Repurposing Breakdown Data by Company
9.2 Rest of World Drug Repurposing Breakdown Data by Type
9.3 Rest of World Drug Repurposing Breakdown Data by Application
9.4 Rest of World Drug Repurposing Breakdown Data by Countries
9.4.1 Rest of World Drug Repurposing Sales by Countries
9.4.2 Rest of World Drug Repurposing Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Astellas Pharma
10.1.1 Astellas Pharma Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Drug Repurposing
10.1.4 Drug Repurposing Product Introduction
10.1.5 Astellas Pharma Recent Development
10.2 Biovista
10.2.1 Biovista Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Drug Repurposing
10.2.4 Drug Repurposing Product Introduction
10.2.5 Biovista Recent Development
10.3 Novartis
10.3.1 Novartis Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Drug Repurposing
10.3.4 Drug Repurposing Product Introduction
10.3.5 Novartis Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Drug Repurposing
10.4.4 Drug Repurposing Product Introduction
10.4.5 AbbVie Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Drug Repurposing
10.5.4 Drug Repurposing Product Introduction
10.5.5 Pfizer Recent Development
10.6 Allergan
10.6.1 Allergan Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Drug Repurposing
10.6.4 Drug Repurposing Product Introduction
10.6.5 Allergan Recent Development
10.7 NuMedii
10.7.1 NuMedii Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Drug Repurposing
10.7.4 Drug Repurposing Product Introduction
10.7.5 NuMedii Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Drug Repurposing Sales Channels
11.2.2 Drug Repurposing Distributors
11.3 Drug Repurposing Customers
12 Market Forecast
12.1 Global Drug Repurposing Sales and Revenue Forecast 2020-2030
12.2 Global Drug Repurposing Sales Forecast by Type
12.3 Global Drug Repurposing Sales Forecast by Application
12.4 Drug Repurposing Forecast by Regions
12.4.1 Global Drug Repurposing Sales Forecast by Regions 2020-2030
12.4.2 Global Drug Repurposing Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
